UNLABELLED: The hallmark of NAFLD is steatosis of unknown etiology. We tested the effect of a high-protein (HP)(2) diet on diet-induced steatosis in male C57BL/6 mice with and without pre-existing fatty liver. Mice were fed all combinations of semisynthetic low-fat (LF) or high-fat (HF) and low-protein (LP) or HP diets for 3weeks. To control for reduced energy intake by HF/HP-fed mice, a pair-fed HF/LP group was included. Reversibility of pre-existing steatosis was investigated by sequentially feeding HF/LP and HF/HP diets. HP-containing diets decreased hepatic lipids to ~40% of corresponding LP-containing diets, were more efficient in this respect than reducing energy intake to 80%, and reversed pre-existing diet-induced steatosis. Compared to LP-containing diets, mice fed HP-containing diets showed increased mitochondrial oxidative capacity (elevated Pgc1α, mAco, and Cpt1 mRNAs, complex-V protein, and decreased plasma free and short-chain acyl-carnitines, and [C0]/[C16+C18] carnitine ratio); increased gluconeogenesis and pyruvate cycling (increased PCK1 protein and fed plasma-glucose concentration without increased G6pase mRNA); reduced fatty-acid desaturation (decreased Scd1 expression and [C16:1n-7]/[C16:0] ratio) and increased long-chain PUFA elongation; a selective increase in plasma branched-chain amino acids; a decrease in cell stress (reduced phosphorylated eIF2α, and Fgf21 and Chop expression); and a trend toward less inflammation (lower Mcp1 and Cd11b expression and less phosphorylated NFκB). CONCLUSION: HP diets prevent and reverse steatosis independently of fat and carbohydrate intake more efficiently than a 20% reduction in energy intake. The effect appears to result from fuel-generated, highly distributed small, synergistic increases in lipid and BCAA catabolism, and a decrease in cell stress.
UNLABELLED: The hallmark of NAFLD is steatosis of unknown etiology. We tested the effect of a high-protein (HP)(2) diet on diet-induced steatosis in male C57BL/6 mice with and without pre-existing fatty liver. Mice were fed all combinations of semisynthetic low-fat (LF) or high-fat (HF) and low-protein (LP) or HP diets for 3weeks. To control for reduced energy intake by HF/HP-fed mice, a pair-fed HF/LP group was included. Reversibility of pre-existing steatosis was investigated by sequentially feeding HF/LP and HF/HP diets. HP-containing diets decreased hepatic lipids to ~40% of corresponding LP-containing diets, were more efficient in this respect than reducing energy intake to 80%, and reversed pre-existing diet-induced steatosis. Compared to LP-containing diets, mice fed HP-containing diets showed increased mitochondrial oxidative capacity (elevated Pgc1α, mAco, and Cpt1 mRNAs, complex-V protein, and decreased plasma free and short-chain acyl-carnitines, and [C0]/[C16+C18] carnitine ratio); increased gluconeogenesis and pyruvate cycling (increased PCK1 protein and fed plasma-glucose concentration without increased G6pase mRNA); reduced fatty-acid desaturation (decreased Scd1 expression and [C16:1n-7]/[C16:0] ratio) and increased long-chain PUFA elongation; a selective increase in plasma branched-chain amino acids; a decrease in cell stress (reduced phosphorylated eIF2α, and Fgf21 and Chop expression); and a trend toward less inflammation (lower Mcp1 and Cd11b expression and less phosphorylated NFκB). CONCLUSION:HP diets prevent and reverse steatosis independently of fat and carbohydrate intake more efficiently than a 20% reduction in energy intake. The effect appears to result from fuel-generated, highly distributed small, synergistic increases in lipid and BCAA catabolism, and a decrease in cell stress.
Authors: Lydia-Ann L S Harris; Gordon I Smith; Bruce W Patterson; Raja S Ramaswamy; Adewole L Okunade; Shannon C Kelly; Lane C Porter; Samuel Klein; Jun Yoshino; Bettina Mittendorfer Journal: Diabetes Date: 2017-05-04 Impact factor: 9.461
Authors: Nicole E Cummings; Elizabeth M Williams; Ildiko Kasza; Elizabeth N Konon; Michael D Schaid; Brian A Schmidt; Chetan Poudel; Dawn S Sherman; Deyang Yu; Sebastian I Arriola Apelo; Sara E Cottrell; Gabriella Geiger; Macy E Barnes; Jaclyn A Wisinski; Rachel J Fenske; Kristina A Matkowskyj; Michelle E Kimple; Caroline M Alexander; Matthew J Merrins; Dudley W Lamming Journal: J Physiol Date: 2017-12-27 Impact factor: 5.182
Authors: Maria Emília L Monteiro; Analucia R Xavier; Felipe L Oliveira; Porphirio Js Filho; Vilma B Azeredo Journal: World J Gastroenterol Date: 2016-06-14 Impact factor: 5.742
Authors: John P Vu; Leon Luong; William F Parsons; Suwan Oh; Daniel Sanford; Arielle Gabalski; John Rb Lighton; Joseph R Pisegna; Patrizia M Germano Journal: J Nutr Date: 2017-10-25 Impact factor: 4.798
Authors: Mary P Moore; Rory P Cunningham; Ryan J Dashek; Justine M Mucinski; R Scott Rector Journal: Obesity (Silver Spring) Date: 2020-09-06 Impact factor: 5.002
Authors: Torsten Schröder; David Kucharczyk; Florian Bär; René Pagel; Stefanie Derer; Sebastian Torben Jendrek; Annika Sünderhauf; Ann-Kathrin Brethack; Misa Hirose; Steffen Möller; Axel Künstner; Julia Bischof; Imke Weyers; Jörg Heeren; Dirk Koczan; Sebastian Michael Schmid; Senad Divanovic; Daniel Aaron Giles; Jerzy Adamski; Klaus Fellermann; Hendrik Lehnert; Jörg Köhl; Saleh Ibrahim; Christian Sina Journal: Mol Metab Date: 2016-02-02 Impact factor: 7.422